| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |